Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1997 3
1998 1
1999 3
2000 6
2001 1
2002 4
2003 4
2004 18
2005 10
2006 10
2007 5
2008 6
2009 12
2010 16
2011 15
2012 21
2013 14
2014 12
2015 3
2016 4
2017 2
2018 3
2019 1
2020 4
2022 2
2023 0

Text availability

Article attribute

Article type

Publication date

Similar articles for PMID: 19493260

156 results

Results by year

Filters applied: . Clear all
Page 1
Multicenter analysis of effect of high biologic effective dose on biochemical failure and survival outcomes in patients with Gleason score 7-10 prostate cancer treated with permanent prostate brachytherapy.
Stone NN, Potters L, Davis BJ, Ciezki JP, Zelefsky MJ, Roach M, Shinohara K, Fearn PA, Kattan MW, Stock RG. Stone NN, et al. Int J Radiat Oncol Biol Phys. 2009 Feb 1;73(2):341-6. doi: 10.1016/j.ijrobp.2008.04.038. Epub 2008 Jul 1. Int J Radiat Oncol Biol Phys. 2009. PMID: 18597953
High-dose radiation employing external beam radiotherapy and high-dose rate brachytherapy with and without neoadjuvant androgen deprivation for prostate cancer patients with intermediate- and high-risk features.
Vargas C, Martínez A, Galalae R, Demanes J, Harsolia A, Schour L, Nuernberg N, Gonzalez J. Vargas C, et al. Prostate Cancer Prostatic Dis. 2006;9(3):245-53. doi: 10.1038/sj.pcan.4500882. Epub 2006 Jun 20. Prostate Cancer Prostatic Dis. 2006. PMID: 16786040
Year of treatment as independent predictor of relapse-free survival in patients with localized prostate cancer treated with definitive radiotherapy in the PSA era.
Kupelian P, Thames H, Levy L, Horwitz E, Martinez A, Michalski J, Pisansky T, Sandler H, Shipley W, Zelefsky M, Zietman A, Kuban D. Kupelian P, et al. Int J Radiat Oncol Biol Phys. 2005 Nov 1;63(3):795-9. doi: 10.1016/j.ijrobp.2005.03.029. Epub 2005 May 31. Int J Radiat Oncol Biol Phys. 2005. PMID: 15925452
156 results